- Home
- SAVA vs UP Comparison
SAVA vs UP Comparison
Compare SAVA & UP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- UP
- Stock Information
- Founded
- SAVA 1998
- UP 2013
- Country
- SAVA United States
- UP United States
- Employees
- SAVA N/A
- UP 2206
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- UP Aerospace
- Sector
- SAVA Health Care
- UP Consumer Discretionary
- Exchange
- SAVA Nasdaq
- UP Nasdaq
- Market Cap
- SAVA 1.3B
- UP 1.4B
- IPO Year
- SAVA N/A
- UP N/A
- Fundamental
- Price
- SAVA $26.91
- UP $2.01
- Analyst Decision
- SAVA Strong Buy
- UP
- Analyst Count
- SAVA 3
- UP 0
- Target Price
- SAVA $111.50
- UP N/A
- AVG Volume (30 Days)
- SAVA 1.3M
- UP 882.5K
- Earning Date
- SAVA 11-07-2024
- UP 11-07-2024
- Dividend Yield
- SAVA N/A
- UP N/A
- EPS Growth
- SAVA N/A
- UP N/A
- EPS
- SAVA N/A
- UP N/A
- Revenue
- SAVA N/A
- UP $833,669,000.00
- Revenue This Year
- SAVA N/A
- UP $38.03
- Revenue Next Year
- SAVA N/A
- UP $25.66
- P/E Ratio
- SAVA N/A
- UP N/A
- Revenue Growth
- SAVA N/A
- UP N/A
- 52 Week Low
- SAVA $8.79
- UP $1.40
- 52 Week High
- SAVA $42.20
- UP $6.08
- Technical
- Relative Strength Index (RSI)
- SAVA 51.05
- UP 45.85
- Support Level
- SAVA $25.00
- UP $1.98
- Resistance Level
- SAVA $28.18
- UP $2.25
- Average True Range (ATR)
- SAVA 1.81
- UP 0.16
- MACD
- SAVA 0.07
- UP -0.01
- Stochastic Oscillator
- SAVA 62.39
- UP 24.29
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.